Delayed Recurrence of Chromophobe Renal Cell Carcinoma Presenting as Metastatic Duodenal Ulcer.

chromophobe renal carcinoma delayed recurrence duodenal ulcer lymph node dissection non clear cell renal carcinoma renal cell carcinoma surveillance upper gastro-intestinal bleed

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
12 Jul 2020
Historique:
entrez: 14 8 2020
pubmed: 14 8 2020
medline: 14 8 2020
Statut: epublish

Résumé

Renal cancers are one of the common causes of cancer-related morbidity and mortality worldwide. Most primary cases are localized at presentation and are treated with partial or radical nephrectomy with curative intent. However, renal cell carcinoma (RCC) is known for its potential recurrence, sometimes several years after initial management. Many of these recurrent cases commonly metastasize to the liver, kidney, or bone and herald a poor prognosis. We present a case study of nonclear cell RCC, which recurred 33 years after nephrectomy and masqueraded as a duodenal ulcer -- an extremely rare site for metastasis. This is unique as it describes a presentation only sparingly documented in the medical literature and highlights a more extended period of recurrence than currently reported. Moreover, our patient's tumor was chromophobe cell variety, a rare sub-type of nonclear cell RCC, which to our knowledge has never been known to cause duodenal metastasis. Studies have implicated a prognostic role of lymph node involvement at the time of initial diagnosis to predict future recurrence. This case is a drop in the mighty ocean to prompt further investigation on the utility of life-long surveillance protocols and further research evaluating the role of lymph node dissection in preventing such recurrences and high mortality.

Identifiants

pubmed: 32789090
doi: 10.7759/cureus.9154
pmc: PMC7417324
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e9154

Informations de copyright

Copyright © 2020, Jain et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Urol. 2013 Aug;190(2):407-16
pubmed: 23665399
Arch Surg. 1965 Feb;90:192-5
pubmed: 14232942
Urology. 2011 Feb;77(2):379-84
pubmed: 20970828
Rev Urol. 2006 Winter;8(1):1-7
pubmed: 16985554
JCO Oncol Pract. 2020 Jan;16(1):49-50
pubmed: 31721625
J Urol. 2017 Sep;198(3):520-529
pubmed: 28479239
Eur Urol. 2013 Sep;64(3):472-7
pubmed: 22748912
J Clin Oncol. 2006 Jul 1;24(19):3101-6
pubmed: 16809736
Indian J Cancer. 2005 Oct-Dec;42(4):173-7
pubmed: 16391434
Cancer Growth Metastasis. 2015 Nov 29;8:43-9
pubmed: 26640389
World J Clin Cases. 2019 Nov 6;7(21):3474-3485
pubmed: 31750330
Cancer. 2003 Jun 15;97(12):2995-3002
pubmed: 12784334
Iran J Med Sci. 2015 Mar;40(2):175-80
pubmed: 25821299
Cancer. 1997 Sep 1;80(5):987-9
pubmed: 9307203

Auteurs

Nikita Jain (N)

Internal Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, McHenry, USA.

Anchit Bharat (A)

Internal Medicine, Indiana University Health Ball Memorial Hospital, Muncie, USA.

Dipesh Ludhwani (D)

Internal Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, USA.
Internal Medicine, Chicago Medical School, North Chicago, USA.

Karam Khaddour (K)

Internal Medicine, Chicago Medical School, Rosalind Franklin University, McHenry, USA.

Thomas Weyburn (T)

Hematology and Oncology, Advocate Health Care, Crystal Lake, USA.

Classifications MeSH